2,997 Shares in Mesa Laboratories, Inc. (NASDAQ:MLAB) Acquired by Choreo LLC

Choreo LLC acquired a new stake in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 2,997 shares of the medical instruments supplier’s stock, valued at approximately $265,000. Choreo LLC owned about 0.06% of Mesa Laboratories at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in the stock. Quadrant Capital Group LLC increased its holdings in shares of Mesa Laboratories by 515.6% during the fourth quarter. Quadrant Capital Group LLC now owns 277 shares of the medical instruments supplier’s stock valued at $29,000 after acquiring an additional 232 shares in the last quarter. EntryPoint Capital LLC increased its stake in Mesa Laboratories by 35.2% during the 1st quarter. EntryPoint Capital LLC now owns 741 shares of the medical instruments supplier’s stock valued at $81,000 after purchasing an additional 193 shares in the last quarter. Louisiana State Employees Retirement System raised its holdings in Mesa Laboratories by 4.0% in the second quarter. Louisiana State Employees Retirement System now owns 2,600 shares of the medical instruments supplier’s stock worth $226,000 after buying an additional 100 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its stake in shares of Mesa Laboratories by 6.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 2,873 shares of the medical instruments supplier’s stock worth $316,000 after buying an additional 175 shares in the last quarter. Finally, Sequoia Financial Advisors LLC purchased a new stake in shares of Mesa Laboratories during the second quarter valued at approximately $319,000. 90.60% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages recently weighed in on MLAB. Wells Fargo & Company initiated coverage on shares of Mesa Laboratories in a report on Tuesday, August 27th. They issued an “underweight” rating and a $120.00 price objective for the company. Evercore ISI upped their price target on Mesa Laboratories from $106.00 to $120.00 and gave the company an “outperform” rating in a report on Tuesday, August 6th.

Mesa Laboratories Stock Up 2.7 %

MLAB opened at $126.15 on Thursday. The stock has a market capitalization of $682.35 million, a price-to-earnings ratio of -2.68 and a beta of 0.85. The firm has a 50 day moving average price of $119.97 and a 200-day moving average price of $109.49. Mesa Laboratories, Inc. has a twelve month low of $82.86 and a twelve month high of $141.17. The company has a quick ratio of 1.37, a current ratio of 1.94 and a debt-to-equity ratio of 1.38.

Mesa Laboratories (NASDAQ:MLAB) last announced its earnings results on Monday, August 5th. The medical instruments supplier reported $2.29 earnings per share for the quarter, beating analysts’ consensus estimates of $1.74 by $0.55. The business had revenue of $58.17 million during the quarter, compared to analyst estimates of $55.90 million. Mesa Laboratories had a negative net margin of 111.89% and a positive return on equity of 18.95%. Equities research analysts forecast that Mesa Laboratories, Inc. will post 7.91 earnings per share for the current year.

Mesa Laboratories Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, September 16th. Shareholders of record on Friday, August 30th were given a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 0.51%. The ex-dividend date of this dividend was Friday, August 30th. Mesa Laboratories’s payout ratio is -1.36%.

Insider Activity

In related news, SVP Brian David Archbold sold 1,499 shares of the stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $125.00, for a total value of $187,375.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 5.20% of the company’s stock.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc develops, manufactures, and sells life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. It operates in four segments: Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions.